Many studies have confirmed the merits of metformin to treat type 2 diabetes, but few studies have addressed its effect on the respiratory system. Moreover, vascular endothelial growth factor (VEGF) is critical to many lung functions. In this way, we evaluated the metformin impact on the lung in treated obese Swiss mice, induced by postnatal overnutrition. Glucose and insulin were detected and the insulin resistance index (HOMA) was calculated; inflammatory cells and nitrite/nitrate concentration (NOx) was quantified from bronchoalveolar lavage, collagen and lung VEGF-a was analysed in the lung tissue and lung mechanics were evaluated by methacholineinduced bronchoconstriction. Values of glucose, insulin, HOMA; VEGF-a and collagen demonstrate the partial ability of metformin to improve the effects of obesity. However, metformin is ineffective in re-establishing the inflammation, shows no effects on NOx and does not restore bronchoconstriction in obese mice. In conclusion, metformińs beneficial effects on lung are questionable in the postnatal overnutrition model of obesity.
Introduction
Currently, metformin, or metformin hydrochloride, a synthetic dimethyl biguanide, is considered the first choice of drug for treating type 2 diabetes (Triggle and Ding, 2017) . It has many actions, which include intestinal glucose uptake and increased insulin-mediated glucose disposal, translocation of glucose transporters, suppression of hepatic glucose output and fatty-acid oxidation. The metformin mechanism could be mediated by the adenosine monophosphate-activated protein kinase, AMPK (Triggle and Ding, 2017; Ismaiel et al., 2016; Yang et al., 2016; Zou et al., 2004) . What is more, metformin attenuates inflammation (Saisho, 2015) and autoimmune encephalomyelitis (Nath et al., 2009) , as well as having vasculoprotective properties (Wiernsperger, 2000) , especially in the glycocalyx barrier (Eskens et al., 2013) , and it is used in the prevention and treatment of cancer (Evans et al., 2005) , along with other beneficial effects. In contrast, the toxicity of metformin is related to metabolic impairment that results in liver and kidney diseases. Its toxicity, which is mainly associated with lactic acidosis, can occur through both acute and chronic exposure (DePalo et al., 2005) . Metformin is gradually being recognized as a drug that can act on the CNS and might accelerate the onset and/or progression of Parkinsońs disease (Ismaiel et al., 2016) .
Despite being a widely used drug, the impact of metformin on the respiratory system is not well established. Shore et al. (2008) performed a study that shows that metformin has no effect on the hyperresponsiveness of ozone-induced increases in inflammatory markers in genetically modified obese mice. Calixto et al. (2013) , using high-fat-dietinduced obesity and ovalbumine-induced asthma in mice; evaluated the metformin effect on lung; however, the study focused on asthma.
VEGF was originally described as a vascular permeability factor; however, it has many other functions (Lee et al., 2011) . VEGF-a (the first member to be discovered) expression is generally modulated by the hypoxia-inducible factor (HIF-1), and in regard to asthma, it was shown that AMPK activation can regulate the HIF/VEGF-a pathway (Park et al., 2012a) . The VEGF-a receptors, are VEGFR-1 and VEGFR-2, the latter is a kinase domain receptor and is responsible for most of the VEGF effects on endothelial cells, such as cell proliferation, nitric oxide (NO) and prostacyclin production, angiogenesis and vascular permeability (Voelkel et al., 2006) . The lung tissue is very rich in this protein and it is critical in the development of lung structure and function (Voelkel et al., 2006) , it also important in eosinophilic inflammation, mucus metaplasia, airway remodelling (subepithelial collagen deposition), smooth muscle hyperplasia, and hyperresponsiveness (Lee et al., 2004) . What is more, in asthmatic mice, metformin reduces expression of various growth factors (Park et al., 2012b) .
The aim of our study was to examine the ability of metformin to adjust the glucose and insulin plasmatic levels, its effect on the inflammatory cells and oxide nitric concentration of the bronchoalveolar lavage fluid, the collagen content and vascular endothelial growth factor level of the lung tissue, as well as assess the lung mechanics with methacholine-induced bronchoconstriction over time in a mice obesity model that was induced by postnatal overnutrition.
Materials and methods

Animals and experimental outline
All procedures performed in the present study complied with the defined guidelines of the institutional animal care committee (protocol number 606/2014) and all animals were treated with respect, dignity and compassion.
The mice were housed at 22 ± 2°C and maintained in a 12:12 h light-dark cycle. They were fed normal chow and water ad libitum. The obese Swiss mice were obtained by postnatal overnutrition (Teixeira et al., 2016) . Briefly, on postnatal day one, the newborn male mice were randomly distributed into litters of 3 pups per dam with 9 dams for reduced litter size, as well as 12 pups per dam in 3 dams for normal litter size. Each litter represented pups from two to five different dams to increase genetic variability within the litter. After being weaned, all male pups were fed normal chow. At the age of 7 weeks, the mice were weighed and handled for water intake measurements. The reduced litter was designated as the obese group, and the normal litter was designated as the control group (CC, reference group). The obese group was divided into the obese control (OC) and the obese treated with metformin (OM) groups.
Group CC and OC received normal drinking water, while group OM received metformin (Medley; 300 mg/kg/day) in their drinking water. The mice were individually housed, the consumed water was carefully monitored for 2 weeks, i.e., during treatment period. Daily intake of water was estimated by weighing the water bottle, and the values were calculated as the rate per day (water intake g/body mass 10 g). At the end of the designated period, all animals were weighed and nasoanal length was determined in order to calculate the Lee Obesity Index (Novelli et al., 2007) . The groups were used for tissue measurements (biochemistry and histology parameters) or respiratory mechanics analysis. The total number of animals was 63 mice.
Biochemistry parameters and sample handling
After 12 h of fasting, the caudal vessels were punctured using a portable glucose meter (Accu-Chek Roche), to obtain blood glucose measurements, To perform insulin measurements, the mice were handled under inhaled anaesthesia (isoflurane) to obtain a blood sample. The blood samples were collected and the plasm was centrifuged at 5300 rpm for 10 min at 4°C and stored in a refrigerator. From these frozen plasm samples, the insulin plasmatic level was determined using an insulin ELISA kit (EZRMI-13 K, Millipore Corporation, MA, USA).
Using the fasting plasma glucose and serum insulin concentration, the insulin resistance index (HOMA-IR) was calculated using the following formula: fasting plasma glucose (mmol/L) x fasting serum insulin (mU/L/22.5) (Kim et al., 2014; Wallace et al., 2004) .
Bronchoalveolar lavage fluid (BALF) cells and nitrite/nitrate concentration (NOx)
The BALF was collected from the same mouse as the blood sample. After obtaining the blood sample, the mice were tracheostomized to obtain the lavage fluid. For this procedure, 2.5 mL of PBS was instilled in the trachea. The concentration of white blood cells (WBC) in BALF was examined by haemocytometer chamber, and viability was assessed by trypan blue dye exclusion. BALF-cell differential was determined from preparations stained with May-Grünwald/Giemsa. Differential cell count (%) was evaluated manually by counting at least 200 BALF cells per sample.
The BALF was evaluated to measure the nitrite/nitrate concentration (NOx) by the Griess reaction (Green et al., 1982) . Briefly, 90 μL was placed in a 96-well plate and incubated for 3 h at room temperature with 10 μL of 0.7 U/ml nitrate reductase (NADPH Sigma-Aldrich). Thereafter, 50 μL of 1% sulfanilamide and 50 μL of 0.1% naphthylethylene diamine were added to each well and incubated for 5 min at room temperature. The absorbance of the mixture at 540 nm was determined by a microplate reader (Synergy H1, hybrid reader, Biotek, EUA) and compared to a standard nitrite curve.
Histological and immunohistochemistry analysis
After collecting the BALF, the right lung was collected, fixed into 10% paraformaldehyde, and embedded in paraffin. To obtain total collagen fiber content four-micron-thick sections were used with picrosirius-polarization methods to quantify the fiber content (%) in the alveolar septa (parenchyma) and airway. Measurements were made under a 200× and 400× magnification on a conventional light microscope with polarization (Nikon, Japan) for alveolar septa and airway, respectively. We performed the analysis on ten non-adjacent fields using the images obtained by the Image Pro-Plus 4.5 software (Media Cybernetics, Silver Spring, MD, USA).
For the VEGF-a immunohistochemistry, seven-micron-thick sections were used, which were deparaffinized and washed with PBS. We incubated the sections with 1% hydrogen peroxide (Sigma, St. Louis, MO, USA) and 1% PBS/BSA (Sigma, St. Louis, MO, USA) for 30 min each and then with the anti-VEGF-a 1:100 (Abcan ® , ab46154) overnight at 4°C. Sections were washed with PBS, incubated with a biotinylated antirabbit 1:500 (Sigma, St. Louis, MO, USA) and with StreptavidinHorseradish Peroxidase (SA-5704, Vector Laboratories, Burlingame, CA) for 1 h each. After washing with PBS, sections were incubated with 3.3-diaminobenzidine (Sigma, St. Louis, MO, USA) in 50 mM TBS containing 0.1% hydrogen peroxide. Sections were counterstained with Harris's haematoxylin, mounted with Entellan (Merck, Darmstadt, Germany) and observed through light microscopy (Níkon Eclipse 80i, Tokyo, Japan). Negative control was obtained by omitting the primary antibody. At least 5 images/captured at 100× magnification were analysed for pixel intensity using the GNU Image Manipulation Program (GIMP 2.8.10 software).
Respiratory mechanics
The animals were previously anaesthetized (pentobarbital sodium, 68 mg/kg, i.p. and xylazine, 12 mg/kg, i.p.), tracheostomized and ventilated (tidal volume of 10 mL/kg, 120 breaths/min and 3 cm of H 2 O positive end expiratory pressure) using a small animal ventilator (flexiVent, SCIREQ, Montreal, Quebec, Canada). Injection of pancuronium bromide (0.5 mL/kg, i.p.) and tramal (50 mg/kg, i.m.) were administered and the animals were kept warm using a heated nest. The pulmonary system input impedance (Zrs) was measured by applying 3 s of oscillatory volume perturbation to the tracheal cannula that was connected to the airway opening. By fitting the constant phase model (Hantos et al., 1992) to the obtained data, the airway resistance (Raw), tissue damping (Gtis), and tissue elastance (Htis) mechanical parameters were estimated. This technique was specially designed to measure the input Zrs in small animals (Gomes et al., 2000) and has previously been described in detail (Hantos et al., 1992; Peták et al., 1997) .
The bronchoconstriction of each mouse was assessed. A saline solution (vehicle, NaCl 0.9%) and methacholine concentration of 100 mg/ mL (MCh, acetyl-β-methylcholine chloride, St. Louis, USA) were aerosolised using an ultrasonic device over a period of 10 s (Aeroneb, Aerogen, Ireland). After 15 s, respiratory mechanics were assessed over 90 s. To standardise lung volume histories, the lungs were inflated once to a pressure of 30 cmH 2 O (recruitment manoeuvre) before the initiation of solution delivery. For each mouse, the parameters of respiratory mechanics were obtained at 30, 60 and 90 s and the data from the highest values of the coefficient of determination (≥0.85) was considered. At the end of the experiment, animals were killed by exsanguination under anaesthesia.
Statistical analysis
Results are expressed as the mean ± SEM. Statistical significance was assessed with parametric methods. One-way analysis of variance (ANOVA) followed by a Tukeýs multiple comparison test was used on all parameters studied. The value of p < 0.05 was considered to be statistically significant. The statistical analyses and graphs were generated using the GraphPad Prism software (version 5.0; San Diego, CA, USA).
Results
The efficiency of this model to induce obesity was evaluated by body mass and the Lee Index (Table 1) . The OC and OM groups had a significant increase in these parameters compared with the CC group (p < 0.0001). Treatment with metformin did not reduce the body mass and did not restore the Lee Index of the OM group.
Plasma glucose and insulin levels as well as HOMA were significantly elevated in both obese groups compared with the CC group. In OC the glucose values were higher compared to CC group (p < 0.005) and in OM group the glucose level remained elevated in comparison to CC group (p < 0.05). These results provided evidence that the metabolic syndrome was established and that the treatment did not repair the metabolic disorder (Table 1) .
With regard to inflammatory cells in BALF (Table 2) , we observed a significant increase in WBC and foamy cells in OC group compared with CC group (p < 0.005 and p < 0.05, respectively). The WBC in the OM group was restored to a similar level of the CC group and the foamy cells were reduced in OM in comparison to CC and OC groups (p < 0.05 and p < 0.005, respectively). In regard to macrophages, we saw a significant reduction in OC in comparison to CC group (p < 0.05). However, the macrophages were increased in the OM in comparison to CC and OC groups (p < 0.005 and p < 0.0001, respectively). No change was observed in the percent of lymphocytes in all groups, furthermore, NOx values were similar in all groups.
Total collagen content (Table 3) was increased in the airway in OC and OM groups in comparison to CC group (p < 0.005 and p < 0.05, respectively). However, the treatment with metformin not repair the airway as was seen in the control group. No difference was detected in the collagen content in the alveolar septa.
The quantification of VEGF-a (Fig. 1 ) was significantly increased in the OC group compared with the CC group (p < 0.005). The OM group displayed reduced levels, of VEGF-a, but this level is different from CC group (p < 0.05). Thus, the results show the incomplete ability of metformin to return the vascular properties of the lung at the basal level seen in the CC group.
The pulmonary mechanics parameters (Raw, Gtis, and Htis; Fig. 2 ) were registered after aerosolization of the saline and methacholine at 30, 60, and 90 s. The bronchoconstriction was evident after methacholine aerosolization at 30 s only in the obese groups (OC and OM) compared with the CC group (p < 0.001 and p < 0.0001, respectively; for details see Fig. 2A ). The metformin treatment did not prevent the early and exacerbated response to methacholine shown by the obese mice at 30 s. At 60 and 90 s the response to methacholine was similar among all groups (Fig. 2B) . The Gtis values after methacholine aerosolization were higher compared to saline aerosolization in all groups at 30, 60, and 90 s (Fig. 2D -F, please see statistical significance level in Fig. legend) . No changes in the Htis values were observed (Fig. 2G-I ).
Discussion
In the present study, we observed that metformin partially improves glucose and insulin levels and consequently, the HOMA-IR indices in obese mice induced by postnatal overnutrition. We also observed limited effects of metformin on inflammatory cells and no changes in NOx in the BALF. In the lung tissue, we also found limited efficacy of this drug to restore the VEGF levels and total collagen content in the obese group. Finally, we found that metformin did not reduce the methacholine-induced bronchoconstriction at any evaluated point of time.
The obese mice used in this study were obtained from postnatal overnutrition, which is an obesity model that is often more representative of natural animal life. The increased availability of milk in the first stage of life allows the mice to become obese, the obesity persists and has substantial influence on the long-term regulation of body mass (Ye et al., 2012) . In our study, the obesity was confirmed using body weight and the Lee Index. The Lee index can also be correlated with the analysis of the percentage of fat in the carcass (Bernardis and Patterson, 1968) and is a reliable and important 67.4 ± 5.1 (7) 93.9 ± 1.4** (7) 40.2 ± 7.9** ### (7) Lymphocyte (%) 2.0 ± 0.40 (8) 1.36 ± 0.24 (7) 1.55 ± 0.30 (7) NOx (μM) 68.6 ± 12 (7) 72.5 ± 8.4 (7) 71.6 ± 12 (6) Values are expressed in mean ± SEM (n). 
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Respiratory Physiology & Neurobiology 247 (2018) 96-102 indicator of obesity. Currently, the drug metformin is mostly used in antihyperglycaemic treatment of type 2 diabetes (Triggle and Ding, 2017; Yang et al., 2016) . The liver and muscle are two primary drug targets of metformin, and adipose tissue could be considered the second prominent target in its blood glucose-lowering action. There are, however, limited reports regarding the impact of this drug on lung in obese mice (Shore et al., 2008; Calixto et al., 2013) . In reports on the liver and muscle, the typical action of metformin is that it inhibits several steps of mitochondrial energy production by AMPK-dependent or by AMPK-independent pathways and improves insulin sensitivity (Triggle and Ding, 2017; Yang et al., 2016) . In the present study, the glucose and insulin levels were not completely recovered, and were still significantly elevated compared with control animal. Shore et al. (2008) reported that the hyperglycaemia was reduced, but not eliminated, in metformin-treated mice. These authors also suggested that the continued elevation of serum glucose may contribute to persistent inflammatory pulmonary response during ozone exposure. In this context, we confirmed that the real efficacy on antihyperglycaemia could be questionable in the present obesity model. In addition, HOMA-IR is a structural model of steady-state insulin and glucose domains, constructed from physiological dose responses of glucose uptake and insulin production. The insulin resistance access by HOMA index is an important tool to indicate glucose metabolism. In the present study the HOMA-IR values were elevated in the OC group, about four times higher than the CC group, and OM group it remained elevated; around two times greater than the CC group.
Nutritional overload is thought to initiate a chronic and unresolved inflammatory response, with an interaction between metabolic (adipocytes) and immune cells, in particular macrophages (Namgaladze and Brüne, 2016) . The adipose tissue macrophages are the principle source of proinflammatory cytokines, which can function in a paracrine and potentially endocrine fashion to cause a systemic decrease in insulin sensitivity (Olefsky and Glass, 2010) . In the lung, a major role of alveolar macrophages is the phagocytosis and clearance of inhaled particulates, preventing damage to the delicate and highly functional epithelium (Lewis et al., 2014) . Once induced, mainly the macrophages can convert into foam cells, as reported in atherosclerotic plaques and renal pathogenesis (Yang et al., 2017; Eom et al., 2015, respectively) . Foam cell produce and secrete reactive oxygen species, oxidized lipoproteins, and there activation and secretion of metalloproteinases, and secretions of pro-inflammatory cytokines and growth factor that promote sclerosis (Eom et al., 2015) . In our study, we observed in the OC group increases in the foam cells and decreases in the macrophage and metformin treatment inverted these data. The metformin effects on lung were reported by Shore et al. (2008) and Calixto et al. (2013) . The latest authors showed the beneficial effects of metformin in pulmonary eosinophilia inflammation induced by ovalbumin in high-fat obese mice. Shore et al. (2008) reported that metformin had no effects on proinflammatory cytokines and chemokines, as well as the neutrophil and macrophage inflammatory proteins in obese female db/db and ob/ ob mice exposed to ozone. Therefore, our data are in agreement with Shore et al. (2008) who reported increased inflammation in the metformin-treated mice.
The NO functions have to be coordinated and controlled to support adequate blood flow and air flow under normal conditions as well as when allergens or immunogens trigger an inflammatory response (Ermert et al., 2002) . NO is involved in many activities in the body and we focused on regulation of obesity and insulin resistance (Sansbury and Hill, 2014) . The NO bioavailability is decreased in animal models of obesity and diabetes (Sansbury and Hill, 2014; Bender et al., 2007) as well as in obese and diabetic humans (Gruber et al., 2008) . In a study of Singh et al. (2015) , they found significantly lower levels of exhaled NO due to the reduction of local arginine bioavailability for NO production in lung of high-fat-diet mice compared to control in a model of metabolic syndrome. In the present study, we measured NOx (nitrate/nitrite concentration) which was maintained at basal level in obese groups as seen in the control animals. Nitrate and nitrite can be considered as endocrine molecules that are transported in the blood, accumulate in tissue and have the potential to be converted back to NO under physiological and pathological conditions (Lundberg et al., 2008) . In vivo and in vitro studies have shown that metformin restored endothelial M.D. Dias et al. Respiratory Physiology & Neurobiology 247 (2018) 96-102 function and improved the NO by increasing the NO synthase via AMPK activation (Saisho, 2015) . In mouse lung tissue, metformin also suppressed ROS and allergic eosinophilic inflammation via AMPK activation in asthmatic animal (Park et al., 2012b) . The VEGF affects proprieties of endothelial cells such as NO and prostacyclin production. The NO is critical to pulmonary circulation and mediates the permeability effects of VEGF (Fukumura et al., 2001 ). In the lung vessel, VEGF, prostacyclin and NO are always intricately linked and form the pillar of their biology (Voelkel et al., 2006) . In asthma, the VEGF is a potent stimulator of inflammation, airway remodelling and physiologic dysregulation (Lee et al., 2004 and Park et al., 2012b) . Our VEGF-a immunocytochemistry data revealed that the OC group treated with metformin show a suppression of VEGF-a in the lung and airway. Nonetheless, we did not see the expected relation between VEGF and NO. We observed a possible correlation of VEGF and total collagen in the airway tissue of the obese mice. However, this intrinsic relation was not made clear with metformin treatment, in which we did not observe an improvement in the airway resistance. Furthermore, VEGF transcription could be regulated by insulin (Voelkel et al., 2006) .
Metformin effects on pulmonary parameters in obese female db/db and ob/ob mice were previously studied by Shore et al. (2008) . These authors reported no effects of metformin with any of the doses of methacholine used. However, they explored the peak response of each methacholine dose with the lung exposed to atmospheric pressure. In the current study, male Swiss mice were induced to obesity by postnatal overnutrition and were submitted to methacholine induced bronchoconstriction. We used only one dose and examined at 30, 60 and 90 s with intact chest. At no time did metformin attenuate the bronchoconstriction observed in the OC group. The greatest difference was 30 s after aerosolized methacholine, in which the obese groups had early and increased bronchoconstriction with the airway resistance increasing two-fold. Using the same obesity model, Ye et al. (2012) studied the relation of the obesity, inflammation and remodelling with airway hyperresponsiveness. Our team, studying the same obesity model of those authors, reported an elevated bronchoconstriction in response to methacholine in obesity (Teixeira et al., 2016) . In the present work, we analyse metformin, considered an endothelial recovery drugs, on airway resistance and observed that it did not reduce the bronchoconstriction induced by methacholine in OC group, although the collagen content and VEGF were reduced.
With an in vitro, culture of airway smooth muscle cells (ASMC), metformin treatment was able to suppress proliferation and possibly the consequent hyperresponsiveness (Liu et al., 2016) . These authors propose that mechanisms of platelet derived growth factor stimulate airway smooth muscle cell proliferation by phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/ mTOR) pathway-mediated up-regulation of S-phase kinase-associated protein 2 (Skp2) and subsequent down-regulation of cyclin dependent kinase inhibitor 1B (p27) and activation of AMPKα2 by metformin suppressed ASMC proliferation induced by growth factor. Nonetheless, no consensus has been reached on its mechanism of action via AMPK. Kristensen et al. (2013) reported that two weeks of metformin treatment did not affect mitochondrial function or protein in wild-type mice, although in contrast, the mitochondrial deficient model of kinase dead mice exhibited enhanced mitochondrial respiration by metformin in skeletal muscle. Singh et al. (2013) stated that an obvious potential factor affecting the lung is insulin itself; in particular there is a direct effect on cell structure and function as well as on immune cells in the airway. Additionally, glucose influences the permeability of endothelial cells (Scalia et al., 2007) and activation of parasympathetic pre-ganglionic nerves contributes to increases in airway reactivity in obese mice (Leiria et al., 2015) .
Conclusion
As seen in the current study, obese mice induced by postnatal overnutrition and treated with metformin promoted limited improvement in the levels of glucose and insulin in the plasma, as well as in the HOMA-IR while having no registered effects on NOx. Moreover, metformin did not restore the macrophages in the BALF, but showed decreases in the VEGFa level and total collagen in the airway in the obese mice. Despite these improvements, this drug was inefficient to repair lung function evaluated by methacholine-induced bronchoconstriction in the obese mice induced by overnutrition. Thus, the ineffectiveness of metformin to promote an overall improvement in the lung was shown in the present study. However, different animal obesity models and different phases of the metabolic syndrome should be explored to clarify the actions of metformin on the lung.
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